Cargando…

Cardiovascular Complications of Prostate Cancer Treatment

Treatment of prostate cancer (PC) is a rapidly evolving field of pharmacology research. In recent years, numerous novel therapeutics that improve survival and ameliorate disease control have been approved. Currently, the systemic treatment for prostate neoplasm consists of hormonal therapy, chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilk, Michał, Waśko-Grabowska, Anna, Szmit, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783464/ https://www.ncbi.nlm.nih.gov/pubmed/33414715 http://dx.doi.org/10.3389/fphar.2020.555475

Ejemplares similares

Angiotensin System Inhibitors May Improve Outcomes of Patients With Castration-Resistant Prostate Cancer During Abiraterone Acetate Treatment—A Cardio-Oncology Study
por: Wilk, Michał, et al.
Publicado: (2021)

Cardiac Biomarkers and Geriatric Assessment in Metastatic Castrate-Resistant Prostate Cancer During Abiraterone Acetate Therapy – A Cardio-Oncology Study
por: Wilk, Michał, et al.
Publicado: (2022)

Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer
por: Zaborowska-Szmit, Magdalena, et al.
Publicado: (2020)

Are cardiovascular comorbidities always associated with a worse prognosis in patients with lung cancer?
por: Mędrek, Sabina, et al.
Publicado: (2022)

Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes
por: Ng, Hooi Hooi, et al.
Publicado: (2018)

Editorial: Translational Approaches for Targeting Cardiovascular Complications of Diabetes
por: Sharma, Arpeeta, et al.
Publicado: (2021)

BH3 Mimetics for the Treatment of Prostate Cancer
por: Wolf, Philipp
Publicado: (2017)

IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus
por: Peiró, Concepción, et al.
Publicado: (2017)

The Sooner, the Better: The Establishment of a Treatment Paradigm in Prostate Cancer
por: Buonerba, Carlo, et al.
Publicado: (2017)

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
por: Li, Ke, et al.
Publicado: (2019)

Sorafenib in progressive castrate-resistant prostate cancer. Can we talk about a new therapeutic option?
por: Zaborowska, Magdalena, et al.
Publicado: (2012)

Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin
por: Szmit, Sebastian, et al.
Publicado: (2020)

DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
por: Valencia, Inés, et al.
Publicado: (2020)

Coptisine Alleviates Pristane-Induced Lupus-Like Disease and Associated Kidney and Cardiovascular Complications in Mice
por: Yan, Yu, et al.
Publicado: (2020)

A Nano-Pharmaceutical Formula of Quercetin Protects from Cardiovascular Complications Associated with Metabolic Syndrome
por: Ahmed, Osama A. A., et al.
Publicado: (2021)

A Mini-Review of Flavone Isomers Apigenin and Genistein in Prostate Cancer Treatment
por: Ji, Xiaozhen, et al.
Publicado: (2022)

Phytochemicals as Potential Therapeutics for SARS-CoV-2–Induced Cardiovascular Complications: Thrombosis and Platelet Perspective
por: Beura, Samir K., et al.
Publicado: (2021)

Cardiovascular adverse effects associated with the use of anti-HER2 in breast cancer treatment
por: Valente, Patricia Marques Soares, et al.
Publicado: (2023)

9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice
por: Wang, Yan-Mei, et al.
Publicado: (2021)

The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
por: Shraim, Bara A., et al.
Publicado: (2021)

Cardiovascular Toxicity Induced by Chronic Vincristine Treatment
por: Herradón, Esperanza, et al.
Publicado: (2021)

Effects of Puerarin on the Prevention and Treatment of Cardiovascular Diseases
por: Zhou, Yan-Xi, et al.
Publicado: (2021)

Corrigendum: 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice
por: Wang, Yan-Mei, et al.
Publicado: (2022)

Treatment-Emergent Co-Morbidities and Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide
por: Lin, Yi-Ting, et al.
Publicado: (2021)

ANO1-downregulation induced by schisandrathera D: a novel therapeutic target for the treatment of prostate and oral cancers
por: Park, SeonJu, et al.
Publicado: (2023)

Characterization of Cardiovascular Alterations Induced by Different Chronic Cisplatin Treatments
por: Herradón, Esperanza, et al.
Publicado: (2017)

Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases
por: Yang, Fangyu, et al.
Publicado: (2022)

MicroRNAs and Natural Compounds Mediated Regulation of TGF Signaling in Prostate Cancer
por: Javed, Zeeshan, et al.
Publicado: (2021)

Evaluation of JQ1 Combined With Docetaxel for the Treatment of Prostate Cancer Cells in 2D- and 3D-Culture Systems
por: Xu, Yipeng, et al.
Publicado: (2022)

Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma
por: Naseer, Faiza, et al.
Publicado: (2021)

Herbal medicine used in the treatment of cardiovascular diseases in the Rif, North of Morocco
por: Chaachouay, Noureddine, et al.
Publicado: (2022)

Prior Cardiovascular Treatments—A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction
por: Campain, Anna, et al.
Publicado: (2022)

Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications
por: Zhuang, Tongxi, et al.
Publicado: (2021)

Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular Mechanisms
por: Bilani, Nadeem, et al.
Publicado: (2017)

Dietary stilbenes as modulators of specific miRNAs in prostate cancer
por: Levenson, Anait S.
Publicado: (2022)

Comparison of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Failure: A Systematic Review and Network Meta-analysis
por: Chen, Junru, et al.
Publicado: (2022)

Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update
por: Roguljic, Hrvoje, et al.
Publicado: (2021)

Higher Risk of Cardiovascular Diseases in Rheumatoid Arthritis Patients Without Methotrexate Treatment
por: Hloch, Karel, et al.
Publicado: (2021)

Editorial: Targeting pumps, channels and transporters for the treatments of vascular, cardiovascular and kidney diseases
por: Zhang, Jinwei, et al.
Publicado: (2023)

LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
por: Li, Zining, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l36mnbok4unbqc7bufbg6c6bqo